Cannabis Report
High Times
Home > Boards > US OTC > Biotechs > NorthWest Biotherapeutics Inc. (NWBO)

Ask AVII. The length of this trial

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
flipper44 Member Profile
Member Level 
Followed By 79
Posts 14,106
Boards Moderated 0
Alias Born 11/14/13
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 9/13/2018 4:24:26 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/14/2018 4:52:44 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/28/2018 5:23:29 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/28/2018 4:12:19 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/18/2018 5:16:53 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/1/2018 4:34:18 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/31/2018 5:01:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/31/2018 7:03:23 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/21/2018 4:44:29 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/16/2018 5:06:32 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 5/16/2018 4:42:32 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/7/2018 5:26:40 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/2/2018 3:52:43 PM
Traders News Source Issues Research Reports on ANDI, FUSZ, RNVA and NWBO InvestorsHub NewsWire - 4/19/2018 8:00:00 AM
Annual Report (10-k) Edgar (US Regulatory) - 4/17/2018 5:11:43 PM
Revised Proxy Soliciting Materials (definitive) (defr14a) Edgar (US Regulatory) - 4/12/2018 5:26:20 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/9/2018 4:15:48 PM
Proxy Soliciting Materials (revised) (prer14a) Edgar (US Regulatory) - 4/4/2018 5:19:57 PM
Notification That Annual Report Will Be Submitted Late (nt 10-k) Edgar (US Regulatory) - 4/3/2018 6:07:43 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 3/26/2018 5:18:11 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 3/26/2018 5:12:56 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/22/2018 4:41:41 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/20/2018 5:11:43 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/15/2018 5:21:44 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/7/2018 4:06:26 PM
flipper44 Member Level  Thursday, 03/08/18 08:28:59 PM
Re: kfa670 post# 161655
Post # of 191291 
Ask AVII. The length of this trial is creeping up on the time it normally takes to get from invention to market for typical drugs (which often have three consecutive trials). It's a long trial.

Respect Risk. Conduct Your Own Due Diligence. Manage your assets wisely. Diversify.
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist